Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]-

Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]- manufacturers

Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]- Basic information

Product Name:	Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]-
Synonyms:	Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]-;Enpp-1-IN-4
CAS:	2376600-89-2
MF:	C19H19N5O5S
MW:	429.45
EINECS:
Product Categories:
Mol File:	2376600-89-2.mol

Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]- Chemical Properties

density	1.515±0.06 g/cm3(Predicted)
pka	7.50±0.50(Predicted)

Safety Information

MSDS Information

Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]- Usage And Synthesis

Uses	Enpp-1-IN-4 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). Enpp-1-IN-4 has the potential for the research of cancer diseases (extracted from patent WO2019177971A1, compound 1)[1].
References	[1] William Michael Gallatin, et al. Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof. Patent WO2019177971A1.

Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]- Preparation Products And Raw materials

Tag:Sulfamide, N-[4-[(2,3-dihydro-7,8-dimethoxy-2-oxo-1H-imidazo[4,5-c]quinolin-1-yl)methyl]phenyl]-(2376600-89-2) Related Product Information

Ro 20-1724 Bay 60-7550 Cilostamide 8-(4-Chlorophenylthio)-adenosine 3':5'-cyclic monophosphate sodium salt W-7 Hydrochloride Tadalafil